09/04/2024
4:34 PM | 10x Genomics (Issuer)
Teichmann Sarah A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:03 PM | 10x Genomics (Issuer)
10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:04 PM | 10x Genomics (Issuer)
10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:05 PM | 10x Genomics (Issuer)
10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:39 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
7:42 PM | 10x Genomics (Subject)
McAnear Justin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
7:45 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/12/2024
10:16 AM | 10x Genomics (Subject)
ARK Investment Management LLC (Filed by)
| Form SC 13G | |
07/19/2024
3:42 PM | 10x Genomics (Issuer)
Teichmann Sarah A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/26/2024
3:48 PM | 10x Genomics (Issuer)
MATEO ALAN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/13/2024
3:08 PM | 10x Genomics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
8:55 AM | 10x Genomics (Subject)
BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
05/23/2024
6:52 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:53 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:54 PM | 10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:23 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024
3:27 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024
3:17 PM | 10x Genomics (Subject)
McAnear Justin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024
3:23 PM | 10x Genomics (Filer)
| Form PRE 14A | |
03/25/2024
4:15 PM | 10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:16 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:17 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
6:02 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:40 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
6:19 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
5:59 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
6:06 PM | 10x Genomics (Subject)
McAnear Justin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
3:20 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:33 PM | 10x Genomics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/09/2024
7:35 AM | 10x Genomics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
1:08 PM | 10x Genomics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/29/2024
10:43 AM | 10x Genomics (Subject)
BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
01/18/2024
3:49 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:08 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
8:00 AM | 10x Genomics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
3:17 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
3:19 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
4:43 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
4:09 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023
3:37 PM | 10x Genomics (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
11/27/2023
5:16 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳 (Ad) 45M Users | 32,481% Growth Rate
Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open. Claim Exclusive 100% Bonus: $0.25/Share |
11/27/2023
5:18 PM | 10x Genomics (Issuer)
Wilbur James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:15 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:15 PM | 10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:25 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
3:25 PM | 10x Genomics (Subject)
McAnear Justin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
3:29 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
3:30 PM | 10x Genomics (Issuer)
Wilbur James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
5:08 PM | 10x Genomics (Subject)
Wilbur James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
3:22 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
3:33 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:43 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
4:15 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
